Welcome to our dedicated page for Philip Morris news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris stock.
Philip Morris International (PM) maintains a dynamic presence in global markets through strategic initiatives and product evolution. This news hub provides investors and industry observers with essential updates about the company's financial performance, reduced-risk product developments, and regulatory engagements.
Access timely press releases and curated analysis covering PM's quarterly earnings, market expansion strategies, and innovations in smoke-free alternatives like heatsticks and oral nicotine products. Our repository simplifies tracking of critical milestones including acquisition announcements, sustainability efforts, and leadership changes impacting this tobacco industry leader.
All content undergoes rigorous verification to ensure accuracy and relevance for stakeholders monitoring PM's transition toward reduced-risk portfolios. Bookmark this page for streamlined access to operational updates and strategic disclosures from one of the world's largest publicly traded tobacco enterprises.
Philip Morris International (NYSE: PM) held its 2025 Annual Meeting of Shareholders, highlighting significant achievements in its smoke-free transformation. CEO Jacek Olczak reported that the company's smoke-free business reached nearly $15 billion in net revenues, with smoke-free products accounting for 42% of PMI's Q1 2025 total net revenues.
The company's leading brands IQOS and ZYN marked their 10-year anniversaries in 2024. As of December 31, 2024, PMI's smoke-free products were available in 95 markets and used by 38.6 million adults globally. PMI has invested over $14 billion since 2008 in developing and commercializing smoke-free products. The meeting saw approximately 82% shareholder participation, with shareholders electing 11 directors and approving executive compensation and auditor selection.
Philip Morris International (PMI) has announced its 2025 Virtual Annual Meeting of Shareholders, scheduled for May 7, 2025, at 9:00 a.m. ET. The virtual meeting will feature addresses from André Calantzopoulos, Chairman of the Board, and Jacek Olczak, Chief Executive Officer.
As of Q1 2025, PMI's smoke-free business represents 42% of total net revenues, with products available in 95 markets and approximately 38.6 million adult users worldwide. The company has invested over $14 billion since 2008 in developing smoke-free alternatives, focusing on scientific research and product innovation.
Key highlights:
- FDA authorization received for Swedish Match's General snus and ZYN nicotine pouches
- IQOS devices obtained Modified Risk Tobacco Product authorization
- Company expanding beyond tobacco into wellness and healthcare sectors
- Virtual meeting accessible at virtualshareholdermeeting.com/PM2025
Philip Morris International (NYSE: PM) CEO Jacek Olczak addressed global leaders at Semafor's World Economy Summit, highlighting regulatory disparities in smoke-free products access. The company revealed that approximately 20% of global smokers lack legal access to smoke-free alternatives, while cigarettes remain widely available.
Countries prohibiting smoke-free products, like Turkey and Brazil, show slower smoking rate declines, with Turkey's smoking prevalence remaining above 30% since 2014. Conversely, nations embracing smoke-free alternatives like Sweden, Japan, and the US have experienced significant decreases in cigarette sales and smoking rates.
PMI's smoke-free products are now available in 95 markets, used by 38.6 million adults globally, representing 42% of Q1 2025 total net revenues. The company has invested over $14 billion since 2008 in developing and scientifically validating smoke-free alternatives, with FDA authorizations for several products including IQOS devices and ZYN nicotine pouches.
Philip Morris International (PM) reported strong Q1 2025 results with reported diluted EPS growing 24.6% to $1.72 and adjusted diluted EPS increasing 12.7% to $1.69. The company's smoke-free business, representing 42% of total net revenues, showed impressive growth with shipment volumes up 14.4% and net revenues increasing 20.4% organically.
Key highlights include IQOS strengthening its position as the second-largest nicotine brand in markets where present, achieving approximately 77% volume share in the heat-not-burn category. ZYN nicotine pouches in the U.S. exceeded 200 million cans, representing 53% growth. Total PMI shipment volume increased 3.9% to 187.8 billion units.
The company raised its 2025 full-year forecast, now projecting adjusted diluted EPS of $7.36-$7.49, representing 12.0-14.0% growth versus 2024. PMI expects total shipment volume growth of up to 2% and organic net revenue growth of 6-8% for the full year.
Philip Morris International (NYSE: PM) has announced it will host a live audio webcast to discuss its 2025 first-quarter financial results on Wednesday, April 23, 2025, at 9:00 a.m. ET. The results will be released at approximately 7:00 a.m. ET the same day.
The company's smoke-free products were available in 95 markets as of December 31, 2024, with an estimated 38.6 million adult users globally. The smoke-free business contributed approximately 39% of PMI's total full-year 2024 net revenues. Since 2008, PMI has invested over $14 billion in developing and commercializing smoke-free products.
PMI's portfolio includes the IQOS and ZYN brands, following its acquisition of Swedish Match. The company has received FDA authorization for marketing Swedish Match's General snus and ZYN nicotine pouches, as well as versions of IQOS devices and consumables.
Philip Morris International (NYSE: PM) has announced a collaboration with Italian design brand SELETTI at Milan Design Week, introducing the 'Curious X: Sensorium Piazza' installation. The project, running from April 7-13, 2025, at Opificio 31, celebrates IQOS's growing community of over 32 million users who have switched from cigarettes.
The installation represents a reimagined Italian Piazza featuring multisensory experiences and marks the launch of the new IQOS Curious X experiential platform. This initiative aligns with PMI's smoke-free future mission, where smoke-free products currently account for 39% of PMI's total 2024 net revenues.
As of December 31, 2024, PMI's smoke-free products are available in 95 markets, with an estimated 38.6 million adult users globally. The company has invested over $14 billion since 2008 in developing and scientifically validating smoke-free products, aiming to completely end cigarette sales.
Philip Morris International (NYSE: PM) has released its 2024 Integrated Report, marking a decade of its smoke-free transformation journey. The company reached 38.6 million adult users of smoke-free products across 95 markets, with smoke-free products accounting for 39% of total net revenues in 2024.
Key achievements include:
- Six markets generating over 75% of net revenues from smoke-free products
- Over $14 billion cumulative investment in smoke-free products since 2008
- 99% of shipment volume covered by youth access prevention programs
- 61% of manufacturing facilities certified as carbon neutral
The company's smoke-free portfolio, led by brands IQOS and ZYN, continues to expand following the acquisition of Swedish Match. PMI's transformation strategy aims to make cigarettes obsolete through innovative smoke-free alternatives while maintaining strong sustainability practices and regulatory compliance.
Philip Morris International (PMI) announces court approval of a significant legal settlement in Canada through its deconsolidated Canadian affiliate, Rothmans, Benson & Hedges Inc. (RBH). The settlement resolves all tobacco product-related claims and litigation in Canada against RBH and its affiliates.
The approved plan includes a CAD 32.5 billion (USD 22.7 billion) aggregate settlement payment shared between RBH, Imperial Tobacco Canada (ITL), and JTI-Macdonald Corp. RBH will retain CAD 750 million (USD 525 million) in accumulated cash. The settlement will be funded through upfront payments and annual contributions based on the companies' net after-tax income from combustible products.
Key terms include releases from tobacco-related claims, separation of alternative product businesses (heat-not-burn, e-vapor, nicotine pouches) from combustible operations, and operating covenants governing RBH's combustible business. Implementation is expected in 2025, subject to conditions including appeal rights exhaustion.
Philip Morris International (NYSE: PM) has declared a regular quarterly dividend of $1.35 per common share, payable on April 10, 2025, to shareholders of record as of March 20, 2025. The ex-dividend date is March 20, 2025.
The company continues its transformation towards a smoke-free future, having invested over $14 billion since 2008 in developing and commercializing smoke-free products. Following the acquisition of Swedish Match, PMI's portfolio is led by IQOS and ZYN brands. As of December 31, 2024, PMI's smoke-free products were available in 95 markets, with an estimated 38.6 million adult users worldwide. The smoke-free business contributed approximately 39% of PMI's total full-year 2024 net revenues.
Philip Morris International (PM) reaffirms its 2025 full-year forecast during the CAGNY Conference presentation. The company expects reported diluted EPS of $6.55 to $6.68, with adjusted diluted EPS of $7.04 - $7.17, representing a 7.2% to 9.1% increase versus 2024.
The presentation highlights PMI's decade-long progress toward a smoke-free future and its successful smoke-free brands. The company's smoke-free products are now available in 95 markets, with approximately 38.6 million adult users. Smoke-free business accounted for 39% of PMI's total full-year 2024 net revenues.
Since 2008, PMI has invested over $14 billion in developing and commercializing smoke-free products. The company's portfolio expansion includes the acquisition of Swedish Match, creating a global smoke-free champion led by IQOS and ZYN brands.
FAQ
What is the current stock price of Philip Morris (PM)?
What is the market cap of Philip Morris (PM)?
